Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 106 Neoplasm Metastasis 9 Ovarian Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 Prostatic Neoplasms 2 Obesity 2 Carcinoma, Non-Small-Cell Lung 2 Breast Diseases 2 Breast Carcinoma In Situ 2 Breast Cancer Metastatic 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Sexuality 1 Sexual Dysfunctions, Psychological 1 Recurrence 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Patient Acceptance of Health Care 1 Pancreatic Neoplasms 1 Pain 1 Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Beast Cancer 1 Locoregional Recurrence 1 Hyperglycemia 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Hormone Receptor Positive Malignant Neoplasm of Breast 1 HR Positive HER2 Negative Advanced Breast Cancer 1

Interventions

Counseling 3 Surveys and Questionnaires 2 Psychiatric Rehabilitation 2 methyl N-acetylsibirosaminide 1 exemestane 1 black cohosh root extract 1 Therapeutics 1 Testosterone Propionate 1 Testosterone 1 Tamoxifen 1 Sildenafil Citrate 1 Sexual Health 1 Restraint, Physical 1 Radiotherapy 1 Prostatectomy 1 Pilocarpine 1 Phentolamine 1 Papaverine 1 Oncology Nursing 1 High-Energy Shock Waves 1 Educational Status 1 Diet Therapy 1 Aromatase Inhibitors 1 Arginine 1 ArginMax 1 Alprostadil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sexuality × exemestane × Clear all

NCT02467686 2017-03-20

Cimicifuga

Irmandade da Santa Casa de Misericordia de Sao Paulo

Phase 4 Unknown

Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon ⚡